126 related articles for article (PubMed ID: 30370942)
1. Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expression.
Loeff FC; Rijs K; van Egmond EHM; Zoutman WH; Qiao X; Kroes WGM; Veld SAJ; Griffioen M; Vermeer MH; Neefjes J; Frederik Falkenburg JH; Halkes CJM; Jedema I
Am J Hematol; 2019 Jan; 94(1):93-102. PubMed ID: 30370942
[TBL] [Abstract][Full Text] [Related]
2. Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemia.
Johansson P; Klein-Hitpass L; Röth A; Möllmann M; Reinhardt HC; Dührsen U; Dürig J
Eur J Haematol; 2020 Dec; 105(6):786-796. PubMed ID: 32875608
[TBL] [Abstract][Full Text] [Related]
3. High Mutation Frequency of the
Loeff FC; Falkenburg JHF; Hageman L; Huisman W; Veld SAJ; van Egmond HME; van de Meent M; von dem Borne PA; Veelken H; Halkes CJM; Jedema I
J Immunol; 2018 Mar; 200(6):2199-2208. PubMed ID: 29427418
[TBL] [Abstract][Full Text] [Related]
4. Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism.
Taylor VC; Sims M; Brett S; Field MC
Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):919-25. PubMed ID: 9148769
[TBL] [Abstract][Full Text] [Related]
5. The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells.
Almstedt M; Blagitko-Dorfs N; Duque-Afonso J; Karbach J; Pfeifer D; Jäger E; Lübbert M
Leuk Res; 2010 Jul; 34(7):899-905. PubMed ID: 20381863
[TBL] [Abstract][Full Text] [Related]
6. Silencing of genes required for glycosylphosphatidylinositol anchor biosynthesis in Burkitt lymphoma.
Hu R; Mukhina GL; Lee SH; Jones RJ; Englund PT; Brown P; Sharkis SJ; Buckley JT; Brodsky RA
Exp Hematol; 2009 Apr; 37(4):423-434.e2. PubMed ID: 19302917
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
[TBL] [Abstract][Full Text] [Related]
8. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
Ando T; Nishimura M; Oka Y
Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
[TBL] [Abstract][Full Text] [Related]
10. A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia.
Hatırnaz Ng Ö; Fırtına S; Can İ; Karakaş Z; Ağaoğlu L; Doğru Ö; Celkan T; Akçay A; Yıldırmak Y; Timur Ç; Özbek U; Sayitoğlu M
Turk J Haematol; 2015 Jun; 32(2):127-35. PubMed ID: 26316480
[TBL] [Abstract][Full Text] [Related]
11. Use of decitabine for patients with refractory or relapsed acute myeloid leukemia: a systematic review and meta-analysis.
Ma YY; Zhao M; Liu Y; Zhao DF; Wang LX; Chen XP; Li L
Hematology; 2019 Dec; 24(1):507-515. PubMed ID: 31242832
[No Abstract] [Full Text] [Related]
12. Correlation between growth control, neoplastic potential and endogenous connexin43 expression in HeLa cell lines: implications for tumor progression.
King TJ; Fukushima LH; Donlon TA; Hieber AD; Shimabukuro KA; Bertram JS
Carcinogenesis; 2000 Feb; 21(2):311-5. PubMed ID: 10657974
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.
Takeda J; Miyata T; Kawagoe K; Iida Y; Endo Y; Fujita T; Takahashi M; Kitani T; Kinoshita T
Cell; 1993 May; 73(4):703-11. PubMed ID: 8500164
[TBL] [Abstract][Full Text] [Related]
14. Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment.
Brett SJ; Baxter G; Cooper H; Rowan W; Regan T; Tite J; Rapson N
Int Immunol; 1996 Mar; 8(3):325-34. PubMed ID: 8671618
[TBL] [Abstract][Full Text] [Related]
15. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
[TBL] [Abstract][Full Text] [Related]
16. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of miR-125b is required for normal B-cell development.
Li G; So AY; Sookram R; Wong S; Wang JK; Ouyang Y; He P; Su Y; Casellas R; Baltimore D
Blood; 2018 Apr; 131(17):1920-1930. PubMed ID: 29555645
[TBL] [Abstract][Full Text] [Related]
18. High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.
Lasa A; Serrano E; Carricondo M; Carnicer MJ; Brunet S; Badell I; Sierra J; Aventín A; Nomdedéu JF
Ann Hematol; 2008 Mar; 87(3):205-11. PubMed ID: 17909799
[TBL] [Abstract][Full Text] [Related]
19. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract][Full Text] [Related]
20. Hypomethylation of the CTGF gene locus is a common feature of paediatric pre-B acute lymphoblastic leukaemia.
Welch MD; Greene WK; Kees UR
Br J Haematol; 2013 Aug; 162(4):537-41. PubMed ID: 23772794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]